Key facts
- This page summarizes Mark Patrick Guerin's Form 4 filing for Onconova Therapeutics, Inc. (TRAW).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2023, 19:19.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
Footnote F2
Each restricted stock unit is convertible into one share of common stock.
Footnote F3
These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary